In his first press conference as president-elect, Donald Trump insisted pharma was “getting away with murder” due to expensive drug prices.
Not only isn’t print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it’s thriving in a most unlikely environment: the point of care
In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China’s tech giants to snare a slice of a more than $100 billion market
As we continue to debate the proper size and role of government in society, cast your eyes on recent polls by Gallup and Pew that found the majority of Americans felt their income tax was fair.
Do the healthcare and pharma arms of Accenture, Deloitte, PwC, and other consultancies pose an existential threat to traditional healthcare agencies?